An Omaha location page for the R3 Stem Cell network; the clinic's own Freedom Healthcare website no longer exists and no Omaha address is published.
This directory entry lists two websites. The first, stemcelltherapyinheartland.com — the clinic-specific site for the Omaha provider, associated with the name Freedom Healthcare — no longer resolves at all: the domain name does not exist in the public domain name system, so there is no site to read. Whatever local practice that site described cannot be verified, and this listing should be treated with caution.
The second address, r3stemcell.com, does work. R3 Stem Cell is a commercial network which describes itself as operating what it calls Centers of Excellence in more than 80 locations across eight countries, and it publishes an Omaha landing page. That page refers to a team of experts serving the Omaha area but gives no street address, no opening hours and no named local clinician; it directs the reader to a clinic-finder instead.
The treatments named on the Omaha page are amniotic-derived stem cells, which the page says are found in the fluid surrounding a developing baby; umbilical cord derived stem cells, from umbilical cord tissue; adipose (fat-derived) stem cells; bone marrow derived stem cells; platelet rich plasma (PRP, prepared from the patient's own blood); and exosome therapy. The amniotic and umbilical cord material is allogeneic — from a donor — while the fat, bone marrow and platelet preparations would be autologous, from the patient's own body. No supplying tissue bank or laboratory is named for the donor material.
The only person named is the network's chief executive, David Greene, described as holding a medical degree, a doctorate and a master's degree in business administration, and mentioned in connection with a webinar rather than as a treating clinician. The page offers a free initial consultation to determine eligibility and publishes no prices. In practical terms, anyone responding to this listing would need to establish which physical clinic in Omaha they would attend, whether it still exists, who would treat them, and what the total cost would be.
The Omaha page frames the service around pain; the network's wider pages list a far broader range of conditions, including neurological and autoimmune disease, without supporting evidence.
The page names several cell types and, unusually for this network, says which tissue the donor material comes from, though not who supplies it.
No treating clinician is named for Omaha.
No premises are described. The network's Omaha page gives no street address, no opening hours and no description of treatment rooms, imaging or laboratory facilities, directing the reader to a clinic-finder instead. The clinic-specific website formerly listed for this entry no longer exists, so nothing about the actual Omaha premises could be verified.
No prices are published. The page offers a free initial consultation at which eligibility is assessed, so the cost of treatment would only become clear after that appointment.
Profile compiled from information published on the clinic's own website and from the StemCell Registry directory record. Details may change; confirm directly with the clinic before making decisions.